POSTPRANDIAL LIPEMIA - RELIABILITY IN AN EPIDEMIOLOGIC FIELD-STUDY

被引:21
作者
BROWN, SA
CHAMBLESS, LE
SHARRETT, AR
GOTTO, AM
PATSCH, W
机构
[1] BAYLOR COLL MED, DEPT MED, HOUSTON, TX 77030 USA
[2] UNIV N CAROLINA, DEPT BIOSTAT, CHAPEL HILL, NC 27514 USA
[3] NHLBI, EPIDEMIOL & BIOMETRY PROGRAM, BETHESDA, MD 20892 USA
关键词
LIPOPROTEINS; HDL CHOLESTEROL; LDL CHOLESTEROL; TRIGLYCERIDES;
D O I
10.1093/oxfordjournals.aje.a116531
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Ten subjects from the Forsyth County, North Carolina, and Washington County, Maryland, field centers in the Atherosclerosis Risk in Communities Study had two fat tolerance tests within a 10-day period from September 1988 to February 1989 to determine the reproducibility of markers for postprandial lipemia. No significant differences between visits were found in fasting mean plasma lipids, lipoproteins, and apolipoproteins. Postprandial triglycerides and retinyl palmitate were measured at 3.5 and 9.0 hours after the test meal in whole plasma. There were no significant differences in the mean levels of these analytes between visits. The correlation of triglycerides between repeat visits at 9.0 hours (r = 0.87) was stronger than in fasting samples (r = 0.67) or at 3.5 hours (r = 0.69). The mean plasma retinyl palmitate level at 3.5 hours was 15% higher than at the 9.0-hour level. The correlation of repeat measures of retinyl palmitate at 9.0 hours (r = 0.94) was much stronger than at 3.5 hours (r = 0.79). In conclusion, estimates of reliability in postprandial measurements of 9.0-hour triglycerides and retinyl palmitate levels were as strong as fasting lipid measurements of total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, and high density lipoprotein3 cholesterol. and both postprandial triglyceride measurements exceeded that of fasting triglyceride (r = 0.67).
引用
收藏
页码:538 / 545
页数:8
相关论文
共 46 条
[1]   SERUM TRIGLYCERIDES IN CORONARY ARTERY DISEASE [J].
ALBRINK, MJ ;
MAN, EB .
ARCHIVES OF INTERNAL MEDICINE, 1959, 103 (01) :4-8
[2]   LIPOPROTEINS AND APOLIPOPROTEINS IN YOUNG MALE SURVIVORS OF MYOCARDIAL-INFARCTION [J].
ALMUHTASEB, N ;
HAYAT, N ;
ALKHAFAJI, M .
ATHEROSCLEROSIS, 1989, 77 (2-3) :131-138
[3]   PLASMA TRIGLYCERIDE AND CORONARY HEART-DISEASE [J].
AUSTIN, MA .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01) :2-14
[4]   BORDERLINE FASTING HYPERTRIGLYCERIDEMIA - ABSENCE OF EXCESS RISK OF ALL-CAUSE AND CARDIOVASCULAR-DISEASE MORTALITY IN HEALTHY-MEN WITHOUT HYPERCHOLESTEROLEMIA [J].
BARRETTCONNOR, E ;
KHAW, KT .
PREVENTIVE MEDICINE, 1987, 16 (01) :1-8
[5]   ALIMENTARY LIPAEMIA IN MEN WITH CORONARY ARTERY DISEASE AND IN CONTROLS [J].
BARRITT, DW .
BRITISH MEDICAL JOURNAL, 1956, 2 (SEP15) :640-644
[6]  
BERR F, 1984, J LIPID RES, V25, P805
[7]  
BRENNINKMEIJER BJ, 1987, J LIPID RES, V28, P361
[8]   POSTPRANDIAL LIPEMIA IN HEALTH AND IN ISCHEMIC HEART DISEASE - A COMPARISON 3 INDEXXES OF FAT ABSORPTION AND REMOVAL AND THEIR MODIFICATION BY SYSTEMIC HEPARIN ADMINISTRATION [J].
BROWN, DF ;
HESLIN, AS ;
DOYLE, JT .
NEW ENGLAND JOURNAL OF MEDICINE, 1961, 264 (15) :733-&
[9]  
BROWN SA, 1988, CLIN CHEM, V34, P920
[10]  
BROWN SA, 1990, CLIN CHEM, V36, P1662